Exact Mass: 464.1251
Exact Mass Matches: 464.1251
Found 500 metabolites which its exact mass value is equals to given mass value 464.1251
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Hesperetin 7-glucoside
Isolated from water mint (Mentha aquatica). Hesperetin 7-glucoside is found in orange mint, herbs and spices, and green vegetables. Hesperetin 7-glucoside is found in green vegetables. Hesperetin 7-glucoside is isolated from water mint (Mentha aquatica Hesperetin 7-O-glucoside is produced by the enzymatic conversion of Hesperidin. Hesperetin 7-O-glucoside is a potent human HMG-CoA reductase inhibitor and also effectively inhibits the growth of Helicobacter pylori. Antihypertensive effect[1][2].
Hesperetin 5-O-glucoside
Hesperetin 5-O-glucoside is found in fruits. Hesperetin 5-O-glucoside is isolated from peach (Persica vulgaris) stem bark. Isolated from peach (Persica vulgaris) stem bark. Hesperetin 5-glucoside is found in fruits and peach.
Demeclocycline
Demeclocycline is only found in individuals that have used or taken this drug. It is a tetracycline analog having a 7-chloro and a 6-methyl. Because it is excreted more slowly than tetracycline, it maintains effective blood levels for longer periods of time. [PubChem]Demeclocycline inhibits cell growth by inhibiting translation. It binds (reversibly) to the 30S and 50S ribosomal subunit and prevents the amino-acyl tRNA from binding to the A site of the ribosome, which impairs protein synthesis by bacteria. The binding is reversible in nature. The use in SIADH actually relies on a side-effect of tetracycline antibiotics; many may cause diabetes insipidus (dehydration due to the inability to concentrate urine). It is not completely understood why demeclocycline impairs the action of antidiuretic hormone, but it is thought that it blocks the binding of the hormone to its receptor. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
(4aS,5aS,12aS)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboximidic acid
(4as,5as,12as)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboximidic acid is classified as a member of the tetracyclines. Tetracyclines are polyketides having an octahydrotetracene-2-carboxamide skeleton, substituted with many hydroxy and other groups (4as,5as,12as)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboximidic acid is considered to be a practically insoluble (in water) and an extremely strong acidic compound (4as,5as,12as)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboximidic acid can be found in humans.
6-(2-Chlorophenyl)-2-[(4-methylpiperazin-1-yl)methylidene]-8-nitro-4H-imidazo[1,2-a][1,4]benzodiazepin-1-one
Asulacrine
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors
6-((2-((4-(2,4-Dichlorophenyl)-5-(4-methyl-1H-imidazol-2-yl)pyrimidin-2-yl)amino)ethyl)amino)nicotinonitrile
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
Davallialactone
2-[3-[1-[[2-(3,4-Dichlorophenyl)acetyl]-methylamino]-2-pyrrolidin-1-ylethyl]phenoxy]acetic acid
Sibenadet
Caffeoylcalleryanin
Caffeoylcalleryanin is a member of the class of compounds known as phenolic glycosides. Phenolic glycosides are organic compounds containing a phenolic structure attached to a glycosyl moiety. Some examples of phenolic structures include lignans, and flavonoids. Among the sugar units found in natural glycosides are D-glucose, L-Fructose, and L rhamnose. Caffeoylcalleryanin is practically insoluble (in water) and a very weakly acidic compound (based on its pKa). Caffeoylcalleryanin can be found in pear, which makes caffeoylcalleryanin a potential biomarker for the consumption of this food product.
Paederosidic acid
Paederosidic acid is a natural product found in Paederia scandens, Plocama calabrica, and Paederia foetida with data available. Paederosidic acid is isolated from P.?scandens with anticancer and anti‐inflammation activities. Paederosidic acid inhibits lung caner cells via inducing mitochondria-mediated apoptosis[1]. Paederosidic acid is isolated from P.?scandens with anticancer and anti‐inflammation activities. Paederosidic acid inhibits lung caner cells via inducing mitochondria-mediated apoptosis[1].
Hydnocarpin
Hydnocarpin is a natural product found in Lonicera japonica and Verbascum sinaiticum with data available. (Rac)-Hydnocarpin is a flavonoid isolated from Hydnocarpus anthelminthica, and exhibits moderate cytotoxic on cancer cells[1]. (Rac)-Hydnocarpin is a flavonoid isolated from Hydnocarpus anthelminthica, and exhibits moderate cytotoxic on cancer cells[1].
5,7,3,4-Tetrahydroxy-6-C-methylflavanone 7-O-glucosdie
3,5,7,4-Tetrahydroxy-6-methylflavanone 7-glucoside
Pyrifluquinazon
6-(2-chlorophenyl)-2-[(4-methylpiperazin-1-yl)methylidene]-8-nitro-4H-imidazo[1,2-a][1,4]benzodiazepin-1-one
2-O-Acetyl-3-O-(2,4-dimethoxy-6-methylbenzoyl)uridine
Me glycoside,tetra-Ac-beta-Pyranose-4-O-alpha-D-Xylopyranosyl-D-xylose
5,7,3-trihydroxy-4-methoxy isoflavanone 7-O-beta-D-glucopyranoside
1-hydroxy-2,3,5-trimethoxyxanthone 1-O-beta-D-glucoside
1-beta-D-Glucopyranosyloxy-3,5,8-trimethoxy-xanthen-9-on|1-beta-D-glucopyranosyloxy-3,5,8-trimethoxy-xanthen-9-one|3,5,8-trimethoxyxanthone-1-O-glucopyranoside
1-O-alpha-L-arabinofuranosyl-(1->6)-beta-D-galactopyranosyloxy-5-hydroxy-3,4-dimethoxy-benzene|pungen A
10-hydroxy-5,7-dimethoxy-3-methyl-1H-naphtho[2,3c]pyran-1-one-9-O-beta-D-glucopyranoside|paepalantine-9-O-beta-D-glucopyranoside
5,7,3,4-Tetrahydroxy-6-C-methylflavanone 7-O-glucoside
3-Me ether-2,2,3,3,7,7-Hexahydroxy-1,1-biphenanthrene|3-methoxy-2,2,3,7,7-pentahydroxy-1,1-biphenanthrene
(2R,3R)-6-methylaromadendrin 3-O-beta-D-glucopyranoside
Cyclopenta[c]pyran-4-carboxylicacid, 1-(b-D-glucopyranosyloxy)-1,4a,5,7a-tetrahydro-5-hydroxy-7-[[[(methylthio)carbonyl]oxy]methyl]-,(1S,4aS,5S,7aS)-
3-hydroxyl-2-methyl-4H-pyran-4-one-3-O-(6-O-feruloyl)-beta-D-glucopyranoside
1-O-[alpha-L-arabinofuranosyl-(1->6)-beta-D-glucopyranosyl]-4-hydroxy-3,5-dimethoxyphenol|rhyncoside B
4-hydroxy-3-methoxyphenyl beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|4-hydroxy-3-methoxyphenyl-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside
4-[(6-O-acetyl-beta-D-glucopyranosyl)oxy]benzyl protocatechuate|amburoside D
3beta,4-dihydroxy-5-methoxyflavonone-7-O-beta-D-glucopyranoside|irisdichotin A
1-O-beta-D-glucopyranosyl-3,5,6-trimethoxy-xanthone
2,6-dimethoxy-p-hydroquinone 1-O-beta-D-xylopyranosyl-(1->6)-beta-D-glucopyranoside
4-O-beta-D-glucopyranosyl-2-methoxy-9-phenyl-1H-phenalen-1-one
3-(3,4-dihydroxyphenyl)-6-(2-(3,4-dihydroxyphenyl)ethenyl)-3a,4-dihydro-8-hydroxy-4-(2-oxopropylidene)-1h,3h-furo(3,4-c)oxepin-1-one
(3S)-thunberginol E 8-O-beta-D-glucopyranoside|florahydroside I
(-)-4-hydroxy-3,5-dimethoxybenzoic acid 4-O-beta-D-(6-O-benzoyl)glucopyranoside
2,4,6-trihydroxy-4-methoxy-6-acetyl-benzophenone-2-O-beta-D-glucoside|Mahkoside B
(-)-4-methoxy-7-O-beta-D-glucopyranosyl-8,3-dihydroxyflavanone
2-(8-methoxy-6-glucopyranosyl-11H-dibenzo[b,e][1,4]dioxepin-11-yl)acetic acid|boerhaavic acid
dichotomine J|methyl 1-[(1R)-1,2-dihydroxyethyl]-8-(beta-D-glucopyranosyloxy)-9H-beta-carboline-3-carboxylate
6-(oxymethyl)-2-hydroxyphenyl-O-beta-D-glucopyranosyl-(1?6)-beta-D-glucopyranoside
3,4-dimethoxy-5-hydroxyphenyl beta-D-apiofuranosyl(1?6)-beta-D-glucopyranoside|cinnacassoside C
(2E,4E)-5-[(3S)-5-acetyl-8-(beta-D-glucopyranosyloxy)-3,4-dihydro-6-hydroxy-1-oxo-1H-2-benzopyran-3-yl]penta-2,4-dienal|(3S,11E,13E)-5-acetyl-8-(beta-D-glucopyranosyloxy)-6-hydroxy-3-(oxopentadienyl)isochroman-1-one
1,4-di-O-beta-D-gIucopyranosyloxy-2-methoxybenzene
1-Glucosyl-decussatin|1-glucosyloxy-3,7,8-trimethoxyxanthone
1-hydroxy-2,3,7-trimethoxyxanthone 1-O-beta-D-glucoside
Asp Ser Glu Asp
Eriodictiol-7-glucoside
Hesperetin 7-O-beta-D-glucoside is a flavanone 7-O-beta-D-glucoside having hesperetin as the flavanone component. It has a role as a metabolite. It is a flavanone 7-O-beta-D-glucoside, a monomethoxyflavanone, a member of 3-hydroxyflavanones, a dihydroxyflavanone, a monosaccharide derivative and a member of 4-methoxyflavanones. It is functionally related to a hesperetin. Hesperetin 7-O-glucoside is a natural product found in Cunila with data available. Hesperetin 7-O-glucoside is produced by the enzymatic conversion of Hesperidin. Hesperetin 7-O-glucoside is a potent human HMG-CoA reductase inhibitor and also effectively inhibits the growth of Helicobacter pylori. Antihypertensive effect[1][2].
3,4,4,6-Tetrahydroxyaurone 4-O-β-D-glucoside
Homoeriodictyol 7-O-glucoside
Homoeriodictyol 7-O-glucoside is a natural product found in Limonium aureum, Viscum coloratum, and Viscum articulatum with data available.
4-Methoxy-7-O-beta-D-glucopyranosyl-8,3-dihydroxyflavanone
2-[(2S,3S,4S)-3-[(1S)-1-acetyloxyethyl]-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]acetic acid
5-hydroxy-2-[1-hydroxy-4-[(2R,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxycyclohexa-2,5-dien-1-yl]-7-methoxychromen-4-one
C19H28O13_4-Hydroxy-3,5-dimethoxyphenyl 6-O-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranoside
C21H24N2O10_Uridine, 2-acetate 3-(2,4-dimethoxy-6-methylbenzoate)
C19H28O13_5-Hydroxy-2,3-dimethoxyphenyl 4-O-[(2S,3R,4R)-3,4-dihydroxy-4-(hydroxymethyl)tetrahydro-2-furanyl]-beta-D-glucopyranoside
[(2R,3R,4R,5R)-4-acetyloxy-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl] 2,4-dimethoxy-6-methylbenzoate
2-[(2S,3S,4S)-3-[(1S)-1-acetyloxyethyl]-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]acetic acid
Loprazolam
N - Nervous system > N05 - Psycholeptics > N05C - Hypnotics and sedatives > N05CD - Benzodiazepine derivatives D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014151 - Anti-Anxiety Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents C78272 - Agent Affecting Nervous System > C29756 - Sedative and Hypnotic > C1012 - Benzodiazepine D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent
2-[(2S,3S,4S)-3-[(1S)-1-acetyloxyethyl]-5-methoxycarbonyl-2-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3,4-dihydro-2H-pyran-4-yl]acetic acid [IIN-based: Match]
[(2R,3R,4R,5R)-4-acetyloxy-5-(2,4-dioxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl] 2,4-dimethoxy-6-methylbenzoate_major
Cys Cys Cys His
Cys Cys His Cys
Cys Asp Met Pro
Cys Asp Asn Asn
Cys Asp Pro Met
Cys His Cys Cys
Cys Met Asp Pro
Cys Met Pro Asp
Cys Asn Asp Asn
Cys Asn Asn Asp
Cys Pro Asp Met
Cys Pro Met Asp
Asp Cys Met Pro
Asp Cys Asn Asn
Asp Cys Pro Met
Asp Asp Asp Thr
Asp Asp Glu Ser
Asp Asp Ser Glu
Asp Asp Thr Asp
Asp Glu Asp Ser
Asp Glu Ser Asp
Asp Met Cys Pro
Asp Met Pro Cys
Asp Asn Cys Asn
Asp Asn Asn Cys
Asp Pro Cys Met
Asp Pro Met Cys
Asp Ser Asp Glu
Asp Thr Asp Asp
Glu Asp Asp Ser
Glu Asp Ser Asp
Glu Ser Asp Asp
His Cys Cys Cys
Met Cys Asp Pro
Met Cys Pro Asp
Met Asp Cys Pro
Met Asp Pro Cys
Met Pro Cys Asp
Met Pro Asp Cys
Asn Cys Asp Asn
Asn Cys Asn Asp
Asn Asp Cys Asn
Asn Asp Asn Cys
Demeclocycline
Tetracycline which lacks the methyl substituent at position 7 and in which the hydrogen para- to the phenolic hydroxy group is substituted by chlorine. Like tetracycline, it is an antibiotic, but being excreted more slowly, effective blood levels are maintained for longer. It is used (mainly as the hydrochloride) for the treatment of Lyme disease, acne and bronchitis, as well as for hyponatraemia (low blood sodium concentration) due to the syndrome of inappropriate antidiuretic hormone (SIADH) where fluid restriction alone has been ineffective. D - Dermatologicals > D06 - Antibiotics and chemotherapeutics for dermatological use > D06A - Antibiotics for topical use > D06AA - Tetracycline and derivatives J - Antiinfectives for systemic use > J01 - Antibacterials for systemic use > J01A - Tetracyclines > J01AA - Tetracyclines C784 - Protein Synthesis Inhibitor > C1595 - Tetracycline Antibiotic D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents C254 - Anti-Infective Agent > C258 - Antibiotic
Asn Asn Cys Asp
Asn Asn Asp Cys
Pro Cys Asp Met
Pro Cys Met Asp
Pro Asp Cys Met
Pro Asp Met Cys
Pro Met Cys Asp
Pro Met Asp Cys
Ser Asp Asp Glu
Ser Asp Glu Asp
Ser Glu Asp Asp
Thr Asp Asp Asp
CT 99021
TRANS-(+/-)-3,4-DICHLORO-N-METHYL-N-(2-[1-PYRROLIDINYL]CYCLOHEXYL)-BENZENEACETAMIDE METHANESULFONATE SALT
Vatalanib succinate
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C1967 - Tyrosine Kinase Inhibitor D004791 - Enzyme Inhibitors > D047428 - Protein Kinase Inhibitors C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
Sibenadet
C78272 - Agent Affecting Nervous System > C29747 - Adrenergic Agent > C87053 - Adrenergic Agonist
N-[2-[(2-chloro-4,6-dinitrophenyl)azo]-5-(diethylamino)-4-methoxyphenyl]acetamide
2-Deoxy-2-fluoro-1,3,5-tri-O-benzoyl-D-ribofuranose
Cevipabulin
C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C273 - Antimitotic Agent
2,3-O-(1-Methylethylidene)-1-O-(phenylmethyl)-alpha-L-sorbofuranose 6-(4-methylbenzenesulfonate)
Pirlimycin Hydrochloride
D000890 - Anti-Infective Agents > D000900 - Anti-Bacterial Agents > D055231 - Lincosamides C784 - Protein Synthesis Inhibitor > C82922 - Lincosamide Antibiotic C254 - Anti-Infective Agent > C258 - Antibiotic
2s-2-[(2,3-Dihydroxyphenyl)carbonylamino]-3-[(2s)-2-[(2,3-Dihydroxyphenyl)carbonylamino]-3-Hydroxy-Propanoyl]oxy-Propanoic Acid
2-[(4-ethyl-5-thiophen-2-yl-1,2,4-triazol-3-yl)thio]-N-(2-methoxy-3-dibenzofuranyl)acetamide
2-[[5-[(1,3-benzothiazol-2-ylthio)methyl]-4-methyl-1,2,4-triazol-3-yl]thio]-N-[2-(4-morpholinyl)ethyl]acetamide
O-(((1R)-((N-(Phenyl-methoxy-carbonyl)-alanyl)-amino)methyl)hydroxyphosphinyl)3-L-phenyllactate
31712-49-9
Hesperetin 7-O-glucoside is produced by the enzymatic conversion of Hesperidin. Hesperetin 7-O-glucoside is a potent human HMG-CoA reductase inhibitor and also effectively inhibits the growth of Helicobacter pylori. Antihypertensive effect[1][2].
(4S,4aS,5aS,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
(2R)-2-[(2,3-dihydroxybenzoyl)amino]-3-[(2S)-2-[(2,3-dihydroxybenzoyl)amino]-3-hydroxypropanoyl]oxypropanoic acid
6-[(E)-2-(3,4-dihydroxyphenyl)ethenyl]-3-[2-(3,4-dihydroxyphenyl)-6-methyl-4-oxo-2,3-dihydropyran-3-yl]-4-hydroxypyran-2-one
[3-hydroxy-4-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]methyl (E)-3-(3,4-dihydroxyphenyl)prop-2-enoate
(4aS,5aS,12aR)-7-chloro-4-(dimethylamino)-1,6,10,11,12a-pentahydroxy-3,12-dioxo-4a,5,5a,6-tetrahydro-4H-tetracene-2-carboxamide
N-[2-methoxy-4-[[2-[(3-methyl-4-oxo-2-quinazolinyl)thio]-1-oxoethyl]amino]phenyl]-2-furancarboxamide
4-(3,4-dihydroxyphenyl)-6-[(4-fluoro-3-methylphenyl)sulfonylmethyl]-2-oxo-3,4-dihydro-1H-pyrimidine-5-carboxylic acid ethyl ester
Ethyl 4-{[2-(4-methoxyphenyl)imidazo[2,1-b][1,3]benzothiazol-7-yl]carbonyl}piperazine-1-carboxylate
N-(2,4-dimethoxybenzylidene)-2-{2-[3-(trifluoromethyl)anilino]-1,3-thiazol-4-yl}acetohydrazide
7-Chloro-4-(dimethylamino)-6,10,12a-trihydroxy-1,3,11,12-tetraoxo-4,4a,5,5a,6,11a-hexahydrotetracene-2-carboxamide
2-[3-(2-furanylmethyl)-4-imino-6,6-dimethyl-2-oxo-5,8-dihydropyrano[2,3]thieno[2,4-b]pyrimidin-1-yl]-N-phenylacetamide
4-[4-(3,5-Dimethylphenyl)sulfonyl-1-piperazinyl]-2-thiophen-2-ylquinazoline
5-ethyl-N-[2-methoxy-5-(4-morpholinylsulfonyl)phenyl]-4,5,6,7-tetrahydro-1-benzothiophene-2-carboxamide
2-[[3-(benzenesulfonyl)-1-oxopropyl]amino]-6-propan-2-yl-5,7-dihydro-4H-thieno[2,3-c]pyridine-3-carboxylic acid ethyl ester
N-[(4-fluorophenyl)methyl]-2-[(2S,3R,6S)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2S,3S,6R)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
2-[(1R,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1R,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1S,3S,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1S,3R,4aR,9aS)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2R,3S,6S)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2S,3R,6R)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2R,3S,6R)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2R,3R,6S)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2S,3S,6S)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
N-[(4-fluorophenyl)methyl]-2-[(2R,3R,6R)-2-(hydroxymethyl)-3-[(3-methoxyphenyl)sulfonylamino]-3,6-dihydro-2H-pyran-6-yl]acetamide
2-[(1S,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1S,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1R,3R,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
2-[(1R,3S,4aS,9aR)-1-(hydroxymethyl)-6-(methanesulfonamido)-3,4,4a,9a-tetrahydro-1H-pyrano[3,4-b]benzofuran-3-yl]-N-[(2-fluorophenyl)methyl]acetamide
3-[[5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-N-(2-methylphenyl)benzamide
3-[[5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-N-(4-methylphenyl)benzamide
3-[[5-[(2-amino-1,3-thiazol-4-yl)methyl]-4-ethyl-1,2,4-triazol-3-yl]sulfanylmethyl]-N-(3-methylphenyl)benzamide
2-(4-beta-d-Glucosyloxy-1-hydroxy-2,5-cyclohexadienyl)-5-hydroxy-7-methoxychromone
CHIR 99021
C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor > C61074 - Serine/Threonine Kinase Inhibitor
Asulacrine
C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor D000970 - Antineoplastic Agents > D059003 - Topoisomerase Inhibitors > D059005 - Topoisomerase II Inhibitors C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor > C1748 - Topoisomerase Inhibitor C274 - Antineoplastic Agent > C186664 - Cytotoxic Chemotherapeutic Agent > C2842 - DNA Binding Agent D004791 - Enzyme Inhibitors
2-[3-[1-[[2-(3,4-Dichlorophenyl)acetyl]-methylamino]-2-pyrrolidin-1-ylethyl]phenoxy]acetic acid
hesperetin 7-O-beta-D-glucoside
A flavanone 7-O-beta-D-glucoside having hesperetin as the flavanone component.
PLX7922
PLX7922, a RAF inhibitor, can bind with BRAFV600E. PLX7922 inhibits pERK in BRAFV600E cell lines, and activates pERK in mutant NRAS cell lines[1].
1-(2,4-dihydroxy-3-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-one
3,5,8-trimethoxy-1-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
5,7-dihydroxy-2-[(2s,3s)-2-(4-hydroxy-3-methoxyphenyl)-3-(hydroxymethyl)-2,3-dihydro-1,4-benzodioxin-6-yl]chromen-4-one
3'-methoxy-[1,1'-biphenanthrene]-2,2',3,7,7'-pentol
(3-hydroxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)methyl (2e)-3-(3,4-dihydroxyphenyl)prop-2-enoate
3,5,6-trihydroxy-2-(4-hydroxyphenyl)-7-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
5,7-dihydroxy-3-{[(3r,4s,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)chromen-4-one
(2s)-2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-3-{[(2s)-2-{[(2,3-dihydroxyphenyl)(hydroxy)methylidene]amino}-3-hydroxypropanoyl]oxy}propanoic acid
[(2s,3s,4s)-3-[1-(acetyloxy)ethyl]-5-(methoxycarbonyl)-2-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3,4-dihydro-2h-pyran-4-yl]acetic acid
(4s,4as,5as,6s,12as)-7-chloro-4-(dimethylamino)-3,6,10,12,12a-pentahydroxy-1,11-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboximidic acid
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-[2,3,4,5-tetrahydroxy-6-(hydroxymethyl)oxan-2-yl]chromen-4-one
[3,4,5-trihydroxy-6-(1,3,6,7-tetrahydroxy-9-oxoxanthen-2-yl)oxan-2-yl]methyl acetate
(2r,3s,4s,5r,6s)-2-(hydroxymethyl)-6-(3-methoxy-4-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenoxy)oxane-3,4,5-triol
2,3,7-trimethoxy-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}xanthen-9-one
(2r,3r,4r,5r)-4-(acetyloxy)-5-(4-hydroxy-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl 2,4-dimethoxy-6-methylbenzoate
5,7-dihydroxy-3-{[(3r,4r,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)chromen-4-one
3-(3,4-dihydroxyphenyl)-5,7-dihydroxy-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
3,5,7-trihydroxy-2-(3-hydroxy-4-{[(2r,3s,4s,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)chromen-4-one
[(6s,8ar)-8-hydroxy-8a-(hydroxymethyl)-1-methyl-2,5-dioxo-3h,6h-imidazo[1,2-a]pyrazin-6-yl]methyl 2,3-dihydroxy-2-(hydroxymethyl)-1,4-benzoxazine-5-carboxylate
[3,4,5-trihydroxy-6-(4-hydroxy-3-methoxyphenoxy)oxan-2-yl]methyl 3-(3,4-dihydroxyphenyl)prop-2-enoate
(3r,3ar)-3-(3,4-dihydroxyphenyl)-6-[2-(3,4-dihydroxyphenyl)ethenyl]-8-hydroxy-4-(2-oxopropylidene)-3h,3ah-furo[3,4-c]oxepin-1-one
(2e)-1-(2,4-dihydroxy-6-{[(2s,3r,4s,5s,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one
2-(3,5-dihydroxy-4-oxidophenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-1λ⁴-chromen-1-ylium
4-(acetyloxy)-5-(4-hydroxy-2-oxopyrimidin-1-yl)-2-(hydroxymethyl)oxolan-3-yl 2,4-dimethoxy-6-methylbenzoate
3-{[(2s,3r,4s,5s)-5-[(1r)-1,2-dihydroxyethyl]-3,4-dihydroxyoxolan-2-yl]oxy}-2-(3,4-dihydroxyphenyl)-5,7-dihydroxychromen-4-one
5,7-dihydroxy-3-{[(2r,3s,4s,5s,6r)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}-2-(3,4,5-trihydroxyphenyl)chromen-4-one
2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3s,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
5,7-dihydroxy-3-[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]-2-(3,4,5-trihydroxyphenyl)chromen-4-one
(2e)-1-(2,4-dihydroxy-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-one
3,5,7-trihydroxy-2-(4-hydroxyphenyl)-8-{[(4s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
2-(2,4-dihydroxyphenyl)-5,7-dihydroxy-3-{[(2s,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}chromen-4-one
1-(2,4-dihydroxy-3-{[(2r,3s,4r,5r,6s)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}phenyl)-3-(3-hydroxy-4-methoxyphenyl)prop-2-en-1-one
2'-(3,4-dihydroxyphenyl)-6-[2-(3,4-dihydroxyphenyl)ethenyl]-4-hydroxy-6'-methyl-2',3'-dihydro-[3,3'-bipyran]-2,4'-dione
(4s,6s,12as)-7-chloro-4-(dimethylamino)-3,6,10,11,12a-pentahydroxy-1,12-dioxo-4a,5,5a,6-tetrahydro-4h-tetracene-2-carboximidic acid
(2r)-eriodictyol-7-o-β-d-glucopyranosiduronicacid
{"Ingredient_id": "HBIN006544","Ingredient_name": "(2r)-eriodictyol-7-o-\u03b2-d-glucopyranosiduronicacid","Alias": "NA","Ingredient_formula": "C21H20O12","Ingredient_Smile": "C1C(OC2=CC(=CC(=C2C1=O)O)OC3C(C(C(C(O3)C(=O)O)O)O)O)C4=CC(=C(C=C4)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15299","TCMID_id": "7282","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(2s)-eriodictyol-7-o-β-d-glucopyranosiduronicacid
{"Ingredient_id": "HBIN006803","Ingredient_name": "(2s)-eriodictyol-7-o-\u03b2-d-glucopyranosiduronicacid","Alias": "NA","Ingredient_formula": "C21H20O12","Ingredient_Smile": "C1C(OC2=CC(=CC(=C2C1=O)O)OC3C(C(C(C(O3)C(=O)O)O)O)O)C4=CC(=C(C=C4)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15300","TCMID_id": "7283","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
3,4',5,5',7-pentahydroxy-3'-methoxyflavone; 3-o-alpha-l-arabinofuranoside
{"Ingredient_id": "HBIN007236","Ingredient_name": "3,4',5,5',7-pentahydroxy-3'-methoxyflavone; 3-o-alpha-l-arabinofuranoside","Alias": "NA","Ingredient_formula": "C21H20O12","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "8347","PubChem_id": "NA","DrugBank_id": "NA"}
3'-Methyl eriodictyol-7-O-beta-D-glucoside
{"Ingredient_id": "HBIN008940","Ingredient_name": "3'-Methyl eriodictyol-7-O-beta-D-glucoside","Alias": "3'-methyl eriodictyol-7-o-beta-d-glucoside; AC1NSYDS; 3'-methyl eriodictyol-7-o-\u03b2-d-glucoside; 5-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-7-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-2,3-dihydrochromen-4-one; 4',5-Dihydroxy-3'-methoxy-7-(beta-D-glucopyranosyloxy)flavanone","Ingredient_formula": "C22H24O11","Ingredient_Smile": "COC1=C(C=CC(=C1)C2CC(=O)C3=C(C=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O","Ingredient_weight": "464.4 g/mol","OB_score": "7.692083677","CAS_id": "NA","SymMap_id": "SMIT02958;SMIT16616;SMIT19362","TCMID_id": "31617;14411","TCMSP_id": "MOL000337","TCM_ID_id": "NA","PubChem_id": "5319642","DrugBank_id": "NA"}
4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(alpha-D-galactopyranosyloxy)-5,7-dihydroxy-
{"Ingredient_id": "HBIN010405","Ingredient_name": "4H-1-Benzopyran-4-one, 2-(3,4-dihydroxyphenyl)-3-(alpha-D-galactopyranosyloxy)-5,7-dihydroxy-","Alias": "2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxychromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-chromen-4-one; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-4-chromenone; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chromen-4-one; 65549-68-0; 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-3-[(2R,3R,4S,5R,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-chromone","Ingredient_formula": "C21H20O12","Ingredient_Smile": "C1=CC(=C(C=C1C2=C(C(=O)C3=C(C=C(C=C3O2)O)O)OC4C(C(C(C(O4)CO)O)O)O)O)O","Ingredient_weight": "464.38","OB_score": "2.409128692","CAS_id": "65549-68-0","SymMap_id": "SMIT09235","TCMID_id": "NA","TCMSP_id": "MOL007878","TCM_ID_id": "NA","PubChem_id": "6455156","DrugBank_id": "NA"}
6-hydroxyluteolin-7-o-glucoside
{"Ingredient_id": "HBIN012457","Ingredient_name": "6-hydroxyluteolin-7-o-glucoside","Alias": "NA","Ingredient_formula": "C21H20O12","Ingredient_Smile": "C1=CC(=C(C=C1C2=CC(=O)C3=C(C(=C(C=C3O2)OC4C(C(C(C(O4)CO)O)O)O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10354","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
8-hydroxyluteolin-8-β-d-glucopranoside
{"Ingredient_id": "HBIN013784","Ingredient_name": "8-hydroxyluteolin-8-\u03b2-d-glucopranoside","Alias": "8-hydroxyluteolin-8-beta-d-glucopranoside","Ingredient_formula": "C21H20O12","Ingredient_Smile": "COC1=CC(=C2C=C(NC2=C1)C(=O)CC3=CN=CC=C3)OC","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "SMIT15874","TCMID_id": "31211;10353","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}